Results 31 to 40 of about 2,361 (178)

Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins

open access: yesOrphanet Journal of Rare Diseases, 2021
Background RASopathies are a group of syndromes showing clinical overlap caused by mutations in genes affecting the RAS-MAPK pathway. Consequent disruption on cellular signaling leads and is driven by phosphoproteome remodeling.
Javier-Fernando Montero-Bullón   +3 more
doaj   +1 more source

Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies

open access: yesScientific Reports, 2018
RASopathies are a group of heterogeneous conditions caused by germline mutations in RAS/MAPK signalling pathway genes. With next-generation sequencing (NGS), sequencing capacity is no longer a limitation to molecular diagnosis. Instead, the rising number
Gordon K. C. Leung   +16 more
doaj   +1 more source

THE EFFECTIVENESS OF PTPN11 GENE ANALYSIS IN THE PRENATAL DIAGNOSIS OF NOONAN SYNDROME

open access: yesİstanbul Tıp Fakültesi Dergisi, 2021
Objective: Dominant pathogenic variants in 29 RAS-MAPK (Rat-sarcoma-Mitogen-activated-protein-kinase) pathway genes, important for the regulation of cell growth, differentiation, aging and cell-cycle, are responsible for RASopathies, Noonan syndrome (NS)
Güven Toksoy   +8 more
doaj   +1 more source

RASopathies: unraveling mechanisms with animal models

open access: yesDisease Models & Mechanisms, 2015
RASopathies are developmental disorders caused by germline mutations in the Ras-MAPK pathway, and are characterized by a broad spectrum of functional and morphological abnormalities.
Granton A. Jindal   +4 more
doaj   +3 more sources

Risk of autoimmune diseases in patients with RASopathies: systematic study of humoral and cellular immunity

open access: yesOrphanet Journal of Rare Diseases, 2021
Background Abnormalities of the immune system are rarely reported in patients affected by RASopathies. Aim of the current study was to investigate the prevalence of immune system dysfunction in a cohort of patients affected by RASopathies. Study design A
M. A. Siano   +16 more
doaj   +1 more source

Cardiac imaging in RASopathies/mitogen activated protein kinase syndromes

open access: yesCardiogenetics, 2014
RASopathies include a spectrum of disorders due to dysregulation of RAS/mitogen activated protein kinase pathway that plays an essential role in the control of the cell cycle and differentiation.
Rita Gravino, Giuseppe Pacileo
doaj   +1 more source

Non-Mammalian Models for Understanding Neurological Defects in RASopathies

open access: yesBiomedicines
RASopathies, a group of neurodevelopmental congenital disorders stemming from mutations in the RAS/MAPK pathway, present a unique opportunity to delve into the intricacies of complex neurological disorders.
Mario Rodríguez-Martín   +5 more
doaj   +1 more source

Multidisciplinary Management of Costello Syndrome: Current Perspectives

open access: yesJournal of Multidisciplinary Healthcare, 2022
Chiara Leoni,1 Germana Viscogliosi,1 Marco Tartaglia,2 Yoko Aoki,3 Giuseppe Zampino1,4 1Center for Rare Diseases and Birth Defects, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario “A.
Leoni C   +4 more
doaj  

Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer

open access: yesNature Communications, 2022
MEK1 mutations are found in cancer and RASopathies, but their effects remain unclear. Here, the authors reveal a mutant MEK1 structure and qualitative differences in biological properties between the cancer- and RASopathy-associated mutants, providing ...
Yuji Kubota   +10 more
doaj   +1 more source

Assessment of Growth in Cardio‐Facio‐Cutaneous Syndrome

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Cardio‐facio‐cutaneous (CFC) syndrome is a rare, multiple congenital anomaly disorder in which individuals commonly experience faltering growth; however, systematic analysis of growth parameters in this disorder has not been performed. We recruited 69 participants with CFC through CFC International and collected data on assessing height ...
Kari Johnston   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy